Drug profile · INN
liothyronine sodium
TRIOSTAT
liothyronine sodium (TRIOSTAT) is a thyroid hormone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — liothyronine sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
liothyronine sodium (TRIOSTAT) is a thyroid hormone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid hormone receptor agonist
Primary target: Thyroid hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is liothyronine sodium?
liothyronine sodium (TRIOSTAT) is a thyroid hormone receptor agonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for liothyronine sodium?
TRIOSTAT is a marketed brand name for liothyronine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of liothyronine sodium?
liothyronine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.